Machine-assisted Arabic translation is in progress. This page is shown in English pending professional review.

Capabilities · Lyophilization

Pioneers in Lyophilization

Mac-Chem's Boisar plant runs multiple lyophilizers, including 140 L and 400 L units, dedicated to Lyophilized Bulk Sterile API manufacturing, with containment built for cytotoxic compounds.

Lyophilized Bulk Sterile API · 15,000 kg/yr installed capacity

Why lyophilization

A dedicated segment: Lyophilized Bulk Sterile API

Lyophilized Bulk Sterile API is one of Mac-Chem's three API segments, alongside Oncology API and General API. It covers active pharmaceutical ingredients manufactured, freeze-dried, and released in sterile bulk form for formulation partners who require this dosage-form starting material. Mac-Chem markets its lyophilization work under the line "Pioneers in Lyophilization."

Installed equipment

Multiple lyophilizers, including 140 L and 400 L units

The Boisar plant operates multiple lyophilizers, including 140 L and 400 L units, dedicated to freeze-drying sterile bulk API. This equipment sits alongside the plant's 8 stainless-steel and 6 glass-lined reactors, and its steam and dry-heat sterilizers.

Containment

Cytotoxic handling under dedicated containment

Lyophilized Bulk Sterile API manufacturing, including cytotoxic oncology molecules, runs under Mac-Chem's Cat III & IV containment facility, with glove-box technology purpose-built for cytotoxic substances, and under fully automated, GAMP-compliant control.

Capacity

Installed annual capacity

Lyophilized Bulk Sterile API carries an installed annual capacity of 15,000 kg/yr, one of Mac-Chem's three API segments alongside Oncology API (15,000 kg/yr) and General API (10,000 kg/yr).

  • 15,000 kg/yr

    Lyophilized Bulk Sterile API

  • 15,000 kg/yr

    Oncology API

  • 10,000 kg/yr

    General API